Please login to the form below

Not currently logged in
Email:
Password:

Adherium Limited

This page shows the latest Adherium Limited news and features for those working in and with pharma, biotech and healthcare.

NICE recognises Smartinhaler as best practice for asthma care

NICE recognises Smartinhaler as best practice for asthma care

Developed by Auckland, New Zealand-based digital health specialist Adherium Limited, the Smartinhaler technology clips onto standard asthma inhalers to monitor the activation of a patient's inhaler and provide audio ... Garth Sutherland, chief executive

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest appointments

  • ALK Abelló's John Tarplee joins Adherium ALK Abelló's John Tarplee joins Adherium

    Becomes business development SVP for Europe. Melbourne-based Adherium Limited has appointed John Tarplee to the newly-created position of senior vice president of business development, Europe. ... Garth Sutherland, chief executive officer of Adherium,

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics